Working to facilitate rapid translation of scientific discoveries into therapeutics

Aristotelis Bamias

Aristotelis Bamias-1

Aristotelis Bamias, MD

Aristotelis Bamias, MD, is Αssociate Professor at the Medical School, University of Athens, in Greece. He studied Μedicine in the Medical School of the University of Athens and trained in Ιnternal Μedicine and Μedical Οncology in the United Kingdom, at the Hammersmith, Royal Marsden and St Bartholomew’s Ηospitals in London. Professor Bamias successfully completed his thesis at the University of Athens and subsequently obtained a PhD from the University of London, working on the application of monoclonal antibodies to cancer diagnosis and treatment. He served as Lecturer in Medical Oncology at the University of London. He is now a practicing medical oncologist in Greece and is affiliated with the Department of Clinical Therapeutics of the University of Athens at the Alexandra Hospital in Athens.

Professor Bamias is in charge of the laboratory of the Oncology Unit, Department of Clinical Therapeutics, University of Athens and he was the coordinator of the genito-urinary working group of the Hellenic Cooperative Oncology Group (HECOG) for the last 10 years. He also was the representative of HECOG at the European Network Gynaecological Oncological Trial Groups (ENGOT) for the last 3 years. Professor Bamias is a founding member and President of the Directing Committee of the Hellenic Genito-Urinary Cancer Group (HGUCG).

Professor Bamias is a member of the Royal College of Physicians (MRCP, UK), full member of the European Society for Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), the European Society of Gynaecological Oncology (ESGO), the European Society of Translational medicine (EUSTM) and a certified member of the Academy of Translational Medicine Professionals (ATMP). He is also currently a member of the ESMO Faculty for Genitourinary Cancer. His main research focus in oncology is urogenital and gynaecological tumours. A member of several international advisory boards and steering committees of international trials, he has published more than 170 original papers and reviews in peer-reviewed journals with more than 4000 citations by other authors.

2013-2021©European Society for Translational Medicine (EUSTM)